Bommireddy, R.; Munoz, L.E.; Kumari, A.; Huang, L.; Fan, Y.; Monterroza, L.; Pack, C.D.; Ramachandiran, S.; Reddy, S.J.C.; Kim, J.;
et al. Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines 2020, 8, 182.
https://doi.org/10.3390/vaccines8020182
AMA Style
Bommireddy R, Munoz LE, Kumari A, Huang L, Fan Y, Monterroza L, Pack CD, Ramachandiran S, Reddy SJC, Kim J,
et al. Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines. 2020; 8(2):182.
https://doi.org/10.3390/vaccines8020182
Chicago/Turabian Style
Bommireddy, Ramireddy, Luis E. Munoz, Anita Kumari, Lei Huang, Yijian Fan, Lenore Monterroza, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Janet Kim,
and et al. 2020. "Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer" Vaccines 8, no. 2: 182.
https://doi.org/10.3390/vaccines8020182
APA Style
Bommireddy, R., Munoz, L. E., Kumari, A., Huang, L., Fan, Y., Monterroza, L., Pack, C. D., Ramachandiran, S., Reddy, S. J. C., Kim, J., Chen, Z. G., Saba, N. F., Shin, D. M., & Selvaraj, P.
(2020). Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines, 8(2), 182.
https://doi.org/10.3390/vaccines8020182
